Prices for a handful of COVID-19 drug candidates started to rise before researchers began testing them as COVID-19 treatments, according to 46Brooklyn, and that does not bode well for controlling prices of drugs if tests show they work against the coronavirus. But the non-profit group also said it’s not clear what is causing the price increases, so they might be justified. 46Brooklyn recently launched a dashboard for tracking abnormal drug price increases , and it updated that tool to let...